Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Eumycetoma pedis in an Albanian farmer.

Fida M, Saraceno R, Gjylametaj N, Dervishi O, Barbullushi A, Kellici S, Vasili E.

Cutis. 2018 Nov;102(5):E13-E15. No abstract available.

PMID:
30566558
2.

Eruptive xanthomas and pancretitis: clinical, dermatoscopy, confocal and pathological correlation.

Saraceno R, Dattola A, Pietroleonardo L, Pitocco R, Fida M, Chimenti S.

G Ital Dermatol Venereol. 2017 Aug;152(4):394-396. doi: 10.23736/S0392-0488.16.05334-7. No abstract available.

PMID:
28621119
3.

Safety evaluation of apremilast for the treatment of psoriasis.

Dattola A, Del Duca E, Saraceno R, Gramiccia T, Bianchi L.

Expert Opin Drug Saf. 2017 Mar;16(3):381-385. doi: 10.1080/14740338.2017.1288714. Epub 2017 Feb 7.

PMID:
28132578
4.

Oral lichen planus: therapy and phenotype.

Loré B, Saraceno R, Poladas G, Fida M, Khoury C, Arcuri C, Magnato R.

G Ital Dermatol Venereol. 2018 Aug;153(4):459-463. doi: 10.23736/S0392-0488.16.05399-2. Epub 2016 Dec 16.

PMID:
27982545
5.

Crusted scabies in a liver transplant patient mimicking rupioid psoriasis.

Garofalo V, Saraceno R, Milana M, Lenci I, Angelico M, Orlandi A, Bianchi L.

Eur J Dermatol. 2016 Oct 1;26(5):495-496. No abstract available.

PMID:
27297820
6.

Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy.

Chiricozzi A, Cannizzaro MV, Salandri GA, Marinari B, Pitocco R, Dattola A, Regine F, Saraceno R, Bianchi L, Chimenti S, Costanzo A.

J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e128-e129. doi: 10.1111/jdv.13403. Epub 2015 Oct 19. No abstract available.

PMID:
26481299
7.

Efficacy and safety of infliximab in psoriatic patients over the age of 65.

Chiricozzi A, Pavlidis A, Dattola A, Bianchi L, Chimenti MS, Fida M, Saraceno R.

Expert Opin Drug Saf. 2016 Nov;15(11):1459-1462. Epub 2016 Aug 31.

PMID:
27534970
8.

No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agents.

Chiricozzi A, Romanelli M, Saraceno R, Torres T.

Expert Opin Drug Saf. 2016 Dec;15(12):1653-1659. Epub 2016 Aug 31. Review.

PMID:
27554637
9.

Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis.

Bianchi L, Del Duca E, Romanelli M, Saraceno R, Chimenti S, Chiricozzi A.

Expert Opin Drug Metab Toxicol. 2016 Sep;12(9):1121-8. doi: 10.1080/17425255.2016.1206886. Epub 2016 Jul 14. Review.

PMID:
27376729
10.

Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study.

Chiricozzi A, Zangrilli A, Bavetta M, Bianchi L, Chimenti S, Saraceno R.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):304-311. doi: 10.1111/jdv.13771. Epub 2016 Jun 21.

PMID:
27324646
11.

Living with Chronic Spontaneous Urticaria in Italy: A Narrative Medicine Project to Improve the Pathway of Patient Care.

Cappuccio A, Limonta T, Parodi A, Cristaudo A, Bugliaro F, Cannavò SP, Rossi O, Gurioli C, Vignoli A, Parente R, Iemoli E, Caldarola G, De Pità O, Di Nuzzo S, Cancian M, Potenza C, Caminati M, Stingeni L, Saraceno R, Trevisini S, Piccirillo A, Sciarrone C, Panebianco R, Gola M, Costanzo A, Grieco T, Massaroni K, Reale L, Marini MG.

Acta Derm Venereol. 2017 Jan 4;97(1):81-85. doi: 10.2340/00015555-2478.

12.

Small molecules and antibodies for the treatment of psoriasis: a patent review (2010-2015).

Chiricozzi A, Saraceno R, Novelli L, Fida M, Caso F, Scarpa R, Costa L, Perricone R, Romanelli M, Chimenti S, Chimenti MS.

Expert Opin Ther Pat. 2016 Jul;26(7):757-66. doi: 10.1080/13543776.2016.1192129. Epub 2016 Jun 13. Review.

PMID:
27266423
13.

UVA1 Laser in the Treatment of Vitiligo.

Babino G, Giunta A, Esposito M, Saraceno R, Pavlidis A, Del Duca E, Chimenti S, Nisticò SP.

Photomed Laser Surg. 2016 May;34(5):200-4. doi: 10.1089/pho.2015.4004. Epub 2016 Apr 12.

PMID:
27070209
14.

Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab.

Chiricozzi A, Specchio F, Dattola A, Fida M, Bianchi L, Chimenti S, Saraceno R.

J Drugs Dermatol. 2016 Feb;15(2):134-8.

PMID:
26885779
15.

A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast.

Chiricozzi A, Caposiena D, Garofalo V, Cannizzaro MV, Chimenti S, Saraceno R.

Expert Rev Clin Immunol. 2016;12(3):237-49. doi: 10.1586/1744666X.2016.1134319.

PMID:
26692125
16.

New therapeutic approaches in the treatment of anogenital lichen sclerosus: does photodynamic therapy represent a novel option?

Criscuolo AA, Schipani C, Cannizzaro MV, Messinese S, Chimenti S, Piccione E, Saraceno R.

G Ital Dermatol Venereol. 2017 Apr;152(2):117-121. doi: 10.23736/S0392-0488.16.05272-X. Epub 2015 Dec 3.

PMID:
26632959
17.

Atopic dermatitis and dental manifestations.

Perugia C, Saraceno R, Ventura A, Lorè B, Chiaramonte C, Docimo R, Chimenti S.

G Ital Dermatol Venereol. 2017 Apr;152(2):122-125. doi: 10.23736/S0392-0488.16.05224-X. Epub 2015 Oct 7.

PMID:
26446571
18.

Apremilast for the treatment of psoriasis.

Chimenti MS, Gramiccia T, Saraceno R, Bianchi L, Garofalo V, Buonomo O, Perricone R, Chimenti S, Chiricozzi A.

Expert Opin Pharmacother. 2015;16(13):2083-94. Epub 2015 Aug 4. Review.

PMID:
26243735
19.

Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome.

Saraceno R, Lorè B, Pavlidis A, Karaiskou M, Arcuri C, Chimenti S, Magnato R.

G Ital Dermatol Venereol. 2016 Oct;151(5):480-4. Epub 2015 Jun 19.

PMID:
26091275
20.

Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study.

Lolli E, Saraceno R, Calabrese E, Ascolani M, Scarozza P, Chiricozzi A, Onali S, Petruzziello C, Chimenti S, Pallone F, Biancone L.

J Crohns Colitis. 2015 Sep;9(9):699-707. doi: 10.1093/ecco-jcc/jjv068. Epub 2015 Apr 23.

PMID:
25908719

Supplemental Content

Loading ...
Support Center